These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22315963)

  • 21. 2-Amino-3-benzoylthiophene allosteric enhancers of A1 adenosine agonist binding: new 3, 4-, and 5-modifications.
    Lütjens H; Zickgraf A; Figler H; Linden J; Olsson RA; Scammells PJ
    J Med Chem; 2003 May; 46(10):1870-7. PubMed ID: 12723950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineating the mode of action of adenosine A1 receptor allosteric modulators.
    Valant C; Aurelio L; Urmaliya VB; White P; Scammells PJ; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Sep; 78(3):444-55. PubMed ID: 20547736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Salvador MK; Preti D; Tabrizi MA; Moorman AR; Vincenzi F; Borea PA; Varani K
    J Med Chem; 2012 Sep; 55(17):7719-35. PubMed ID: 22889387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers.
    Aurelio L; Figler H; Flynn BL; Linden J; Scammells PJ
    Bioorg Med Chem; 2008 Feb; 16(3):1319-27. PubMed ID: 17980606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery.
    Baltos JA; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
    Biochem Pharmacol; 2016 Jan; 99():101-12. PubMed ID: 26581123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor.
    Baraldi PG; Zaid AN; Lampronti I; Fruttarolo F; Pavani MG; Tabrizi MA; Shryock JC; Leung E; Romagnoli R
    Bioorg Med Chem Lett; 2000 Sep; 10(17):1953-7. PubMed ID: 10987425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
    Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
    Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
    Romagnoli R; Baraldi PG; Moorman AR; Iaconinoto MA; Carrion MD; Cara CL; Tabrizi MA; Preti D; Fruttarolo F; Baker SP; Varani K; Borea PA
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5530-3. PubMed ID: 16931014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Roerink SF; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
    J Med Chem; 2005 Mar; 48(6):2045-53. PubMed ID: 15771447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promiscuous coupling and involvement of protein kinase C and extracellular signal-regulated kinase 1/2 in the adenosine A1 receptor signalling in mammalian spermatozoa.
    Minelli A; Bellezza I; Collodel G; Fredholm BB
    Biochem Pharmacol; 2008 Feb; 75(4):931-41. PubMed ID: 18054348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
    Ferguson GN; Valant C; Horne J; Figler H; Flynn BL; Linden J; Chalmers DK; Sexton PM; Christopoulos A; Scammells PJ
    J Med Chem; 2008 Oct; 51(19):6165-72. PubMed ID: 18771255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.
    Button L; Mireylees SE; Germack R; Dickenson JM
    Exp Physiol; 2005 Sep; 90(5):747-54. PubMed ID: 15964902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.
    Figler H; Olsson RA; Linden J
    Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
    Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
    Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
    Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
    J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: agonist-specific activation pathways and the impact of RNA editing.
    Werry TD; Stewart GD; Crouch MF; Watts A; Sexton PM; Christopoulos A
    Biochem Pharmacol; 2008 Nov; 76(10):1276-87. PubMed ID: 18812172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.